The United States Department of State is seeking project proposals for what could become one of its biggest health transformation ...

Lucid Diagnostics offers asymmetric upside, with Medicare reimbursement as a near-term inflection point unlocking a $2–3M backlog. Read more on LUCD stock here.

India's cancer care is advancing with precision therapies and immunotherapy, but high costs, unequal access, limited diagnostics and insurance leave millions behind, highlighting the need for ...